The global bioinformatics market size is calculated at USD 18.69 billion in 2025 and is forecasted to reach around USD 52.01 billion by 2034, accelerating at a CAGR of 12.05% from 2025 to 2034. The North America market size surpassed USD 7.33 billion in 2024 and is expanding at a CAGR of 12.18% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global bioinformatics market size accounted for USD 16.66 billion in 2024 and is expected to exceed USD 52.01 billion by 2034, growing at a CAGR of 12.05% from 2025 to 2034. The growing investment in biology and information technology industries is directly having a positive impact on the growth of bioinformatics market.
Artificial Intelligence (AI) is finding wide application in biology and information technology sector. This has extended into the field of bioinformatics. The usage of AI is being slowly but steadily integrated into the bioinformatics infrastructure. AI technology combined with machine learning (ML) is helping in extraction of patterns from vast amounts of data to help make informed decisions. The acceleration of the process of drug discovery has become a reality with AI technology. Other benefits of AI in bioinformatics are efficiency, quicker drug discovery, improved prediction models and assistance in personalized medicine. The bioinformatics market is evolving and integration of advanced technology like AI will further boost the market in the forecast period.
The U.S. bioinformatics market size was exhibited at USD 5.13 billion in 2024 and is projected to be worth around USD 16.32 billion by 2034, growing at a CAGR of 12.26% from 2025 to 2034.
North America dominated the bioinformatics market in 2022. The bioinformatics market in North America is growing due to the favorable government regulations in favor of market players. In addition, the growth of North America bioinformatics market is also attributed to the existence of major market players. The government of the U.S. is investing towards the development of bioinformatics market. Furthermore, expanding research and development activities are paving way for the expansion of bioinformatics market in the region.
Europe, on the other hand, is expected to develop at the fastest rate during the forecast period. The UK, Italy, and France dominate the bioinformatics market in Europe region. The growing investments in healthcare sector are driving the growth of Europe bioinformatics market. Moreover, the adoption of innovative technologies such as artificial intelligence and internet of things are contributing towards the growth of bioinformatics market in Europe. The market players operating in Europe bioinformatics market are adopting strategies such as partnership and acquisition.
The combination of biology and information technology is known as bioinformatics. There are a number of tools and software that are regularly utilized in data creation, data management, data warehousing and even data mining. The expansion of pharmaceutical sector has directly helped the growth of bioinformatics market. The impact of the COVID 19 pandemic was positive on this market as it helped open up new opportunities for the industry. Bioinformatics is widely utilized for the development of drugs and vaccines since the pandemic. A growing need for bioinformatics in the process of novel drug research and development has pushed the market growth. Many software are available easily today for the bioinformatics, which are user-friendly. There is an increase in public as well as private funding for the support of research activities will be expected to further help the expansion of the bioinformatics market during the forecast period.
| Report Coverage | Details |
| Market Size in 2025 | USD 18.69 Billion |
| Market Size in 2034 | USD 52.01 Billion |
| Growth Rate | CAGR of 12.05% from 2025 to 2034 |
| Largest Market | North America |
| Fastest Growing Market | Europe |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Segments Covered | Product, Application, Sector, Geography |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Increase in funding from Government and Private Organizations
The governments around the world as well as the private organizations are investing extensively in the field of bioinformatics. The increase in funding and availability of resources is helping integration of technological advancements into the industry. The infrastructure improvement and scope of innovation rises with availability of resources. The field which is seeing more development in the current scenario is genomics. In genomics, huge amounts of data need to be analyzed and technological advancements are helping provide insightful data. The rising funding from public and private sector is helping driving the bioinformatics market.
Cost of equipment
The advancements in technology and availability of tools have increased the precision and speed of bioinformatics industry. These tools are easily available and user friendly to an extent, but require certain level of advanced computer infrastructure and expertise to operate the tools properly. The operation of advanced features as well as instruments need a suitable infrastructure with the capacity to handle such heavy technological functions. This cost of equipment and enhancement of infrastructure is not ease for companies that small or medium size. It necessitates monetary investment which is a challenge for some organizations in the bioinformatics market.
Utilizing bioinformatics in personalized medicine
The rising demand for personalized medicine is growing across the world. The trend for personalized medicine is relatively new in healthcare and there are many avenues left unexplored. The awareness and acceptance amongst the people regarding personalized medicine has led to its rising demand. The development of such customized and personalized medicine could cater to a completely new consumer base. Technological advancement like artificial intelligence (AI) makes the process of discovery and implementation of personalized medicine slightly easier. The application of bioinformatics in personalized medicine could present a new opportunity for the bioinformatics market.
The bioinformatics services segment dominated the bioinformatics market in 2022. The factors such as growing initiatives regarding research and development as well as surge in demand for novel drugs are boosting the growth of bioinformatics services segment. Furthermore, the technological advancements are resulting into the growing demand for bioinformatics services in the global market.
The bioinformatics platforms segment is fastest growing segment of the bioinformatics market in 2024. The growing usage of various tools for database management is driving the growth of bioinformatics platforms. The high utilization of next generation sequencing is also contributing to the growth of bioinformatics platforms. In addition, the growing demand for exome and genome technologies is driving the segment growth.
The genomic segment dominated the bioinformatics market in 2022. The demand for bioinformatics is growing in genomics due to adoption of new and innovative technologies. The bioinformatics in pharmacogenomics are used for handling and managing large amount of data and information in database. The sequencing technology is widely used in drug development process. This is directly impacting the growth of genomic segment over the forecast period.
The proteomics segment is fastest growing segment of the bioinformatics market in 2024. The growth of proteomics segment is attributed to the rising research and development initiatives and high investments for the development of technologies. These technologies help to analyze and manage data on a large scale. Moreover, algorithms are also used for managing and monitoring data in database. All these factors are driving the growth of the proteomics segment.
By Product
By Application
By Sector
By Geography
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Access TOC
Get a Sample